Fungal Superset 18FS - MerLion Pharmaceuticals Pte Ltd

Merlion Pharmaceuticals Pte Ltd 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528 Tel. (65) 6829 5600 Fax...

3 downloads 590 Views 278KB Size
Merlion Pharmaceuticals Pte Ltd 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528 Tel. (65) 6829 5600 Fax. (65) 6829 5601 www.merlionpharma.com

Fungal Superset Product code: 18FS Contents: •

20 x 96-well microtitre plates containing semi-purified natural product samples derived from 80 selected fungal ‘superproducer’ strains



1 x 96-well microtitre plate containing crude extracts derived from 80 selected fungal ‘superproducer’ strains

Introduction The fermentation of fungal strains is well known for producing a huge diversity of secondary metabolites, including many which are medicinally important. MerLion Pharmaceuticals has used its proprietary UPLC/MS/UV/ELSD chemical fingerprinting technology to identify the most chemically diverse and productive samples from its comprehensive fungal extract library. To generate this superset 8,579 fungal extract fingerprints, each representing a single strain and growth medium combination, were analysed. Strains were ranked based on the numbers and diversity of compounds observed within each extract. The extracts from the top 80 ‘superproducer’ strains have been prefractionated by reverse phase HPLC into 20 fractions per extract (see Fig. 1) and arrayed within microtitre plates for easy biological testing. The resulting set of 1600 enriched and semi-purified fractions represents a high quality focused screening library with excellent coverage of fungal secondary metabolite chemistry in comparatively few screening wells. Each fraction has been analysed by UPLC/MS to determine the numbers and uniqueness of compounds within the set as a whole and contributed by each superproducer strain (see Tables 1 and 2). Only compounds showing significant peak intensities versus the background were included in this analysis therefore actual chemical diversity, including minor components, will be even higher. Features: • 80 actinomycete ‘superproducer’ strains specially selected because they yield a large number of chemically diverse compounds • all strains have been characterised taxonomically using 16S rRNA sequencing • over 100-fold enrichment of individual components in screening wells o individual components are concentrated approx. 9-fold compared to the crude extracts o total mass is reduced approx. 12.5 fold • approximately 20 µg of enriched material present within each well (also this will varying according to the properties and distribution of compounds within each extract) • UPLC/MS data available for all fractions

-1-

Merlion Pharmaceuticals Pte Ltd 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528 Tel. (65) 6829 5600 Fax. (65) 6829 5601 www.merlionpharma.com

Fungal Superset Statistics Total number in superset

Average number per fraction

Maximum number per fraction

Compounds*

7,987

23

163

Unique Compounds**

4.478

2.8

45

* Compounds defined as individual mass and retention time combinations in UPLC/MS analysis with mass ion intensities 10 x over intensity threshold ** Compounds which are unique to one extract (i.e. do not occur in any other extracts within the superset)

Example of Fractionation

Figure 1. Overlayed UPLC/UV chromatograms of fractions from strain 18FS-56. Crude extract is shown in red with fractions 2, 4, 6, 8, 10, 12, 14, 16 &18 behind.

-2-

Merlion Pharmaceuticals Pte Ltd 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528 Tel. (65) 6829 5600 Fax. (65) 6829 5601 www.merlionpharma.com

Fungal Superproducer Strains Total Count in Each Extract No.

Sample code

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54

18FS_1 18FS_2 18FS_3 18FS_4 18FS_5 18FS_6 18FS_7 18FS_8 18FS_9 18FS_10 18FS_11 18FS_12 18FS_13 18FS_14 18FS_15 18FS_16 18FS_17 18FS_18 18FS_19 18FS_20 18FS_21 18FS_22 18FS_23 18FS_24 18FS_25 18FS_26 18FS_27 18FS_28 18FS_29 18FS_30 18FS_31 18FS_32 18FS_33 18FS_34 18FS_35 18FS_36 18FS_37 18FS_38 18FS_39 18FS_40 18FS_41 18FS_42 18FS_43 18FS_44 18FS_45 18FS_46 18FS_47 18FS_48 18FS_49 18FS_50 18FS_51 18FS_52 18FS_53 18FS_54

55

18FS_55

56

18FS_56

Strain taxonomy

Sarocladium sp. Aspergillus sp. Aspergillus sp. Penicillium sp. Penicillium sp. Phomopsis sp. Aspergillus sp. Cladosporium sp. Aspergillus sp. Aspergillus sp. Fusarium sp. Aspergillus sp. Aspergillus sp. Phoma herbarum Aspergillus melleus Memmoniella echinata Aspergillus sp. Aspergillus sp. Fusarium sp. Aspergillus sp. Penicillium sp. Penicillium sp. Acremonium sp. Aspergillus sp. Penicillium sp. Fusarium tumidum Aspergillus sp. Penicillium sp. Penicillium sp. Acremonium sp. Penicillium sp. Aspergillus ochraceus Periconia sp. Emericella sp. Aspergillus sp. Pestalotiopsis sp. Stachybotrys parvispora Penicillium sp. Penicillium sp. Penicillium sp. Chaunopychnis sp. Chaetomium sp. Penicillium sp. Microsphaeropsis sp. Plurophoma plurospora Aspergillus sp. Aspergillus sp. Penicillium sp. Aspergillus sp. Trichoderma sp. Penicillium sp. Geomyces sp. Aspergillus sp. Eurotium echinulatum Aureobasidium caulivorum Eurotium cristatum

Plate no.

1 1 1 1 2 2 2 2 3 3 3 3 4 4 4 4 5 5 5 5 6 6 6 6 7 7 7 7 8 8 8 8 9 9 9 9 10 10 10 10 11 11 11 11 12 12 12 12 13 13 13 13 14 14

1

Rows

A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H A,B C,D

14

E,F

14

G,H

-3-

Average No. of Compounds per Fraction

Compounds2

Unique Compounds3

369 236 93 139 255 195 358 182 175 124 195 180 259 204 175 314 63 173 129 220 192 134 323 346 386 75 152 126 562 752 239 166 49 33 140 103 215 32 141 207 218 58 152 66 131 194 324 119 180 226 57 48 392 300

197 54 7 27 62 50 128 51 29 13 45 8 58 70 64 82 11 36 36 68 62 40 131 68 136 23 35 30 143 230 26 54 6 7 38 36 70 5 30 60 78 12 32 8 25 58 82 23 12 54 9 13 71 75

37.6 22.2 8.1 12.4 28.0 20.4 34.7 22.8 19.6 10.5 17.0 13.3 23.4 17.1 13.0 38.4 6.0 17.1 13.4 20.8 21.8 13.1 36.4 38.8 37.0 6.8 13.5 12.3 73.1 104.6 26.5 17.7 4.3 2.7 15.4 9.7 19.7 3.0 13.8 20.4 26.0 4.7 15.7 7.3 12.5 22.2 34.7 11.5 16.6 21.9 5.9 3.3 44.7 29.6

56 262

13 87

3.8 28.0

Merlion Pharmaceuticals Pte Ltd 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528 Tel. (65) 6829 5600 Fax. (65) 6829 5601 www.merlionpharma.com

Table continued…

Total Count in Each Extract No.

Sample code

57 58 59 60 61 62

18FS_57 18FS_58 18FS_59 18FS_60 18FS_61 18FS_62

63

18FS_63

64

18FS_64

65

18FS_65

66 67 68 69 70 71 72 73 74 75 76

18FS_66 18FS_67 18FS_68 18FS_69 18FS_70 18FS_71 18FS_72 18FS_73 18FS_74 18FS_75 18FS_76

77

18FS_77

78 79 80

18FS_78 18FS_79 18FS_80

Strain taxonomy

Nectria cinnamomea Trichothecium roseum Emericella rugulosa Alternaria targetica Nigrospora sphaerica Xylaria anisopleura Arthrinium phaeospermum Acremonium sp. Unidentified hyphomycete Torula sp. Myrothecium sp. Eupenicillum sp. Penicillium sp. Curvularia sp. Penicillium sp. Aspergillus sp. Aspergillus sp. Pseudallescheria boydii Eupenicillum sp. Emericellopsis sp. Trichoderma longibrachiatum Emericella sp. Pestalotiopsis sp. Penicillium sp.

Plate no.

Rows1

15 15 15 15 16 16

A,B C,D E,F G,H A,B C,D

16

E,F

16

G,H

17

A,B

17 17 17 18 18 18 18 19 19 19 19

C,D E,F G,H A,B C,D E,F G,H A,B C,D E,F G,H

20

A,B

20 20 20

C,D E,F G,H

Average No. of Major Compounds per Fraction

Major Compounds2

Unique Major Compounds3

169 423 174 35 112 213

42 104 48 4 47 45

20.6 54.3 17.5 2.3 8.8 24.7

201 438

43 140

22.0 48.7

322 143 266 278 160 182 255 343 349 178 339 437

147 31 92 64 17 41 48 21 50 34 78 177

37.0 15.6 33.3 27.9 16.9 23.1 22.9 50.4 46.6 19.9 28.2 46.9

304 243 134 262

103 61 7 56

33.6 26.4 14.8 36.3

1

Fractions are arranged sequentially in columns 1 to 10 in two consecutive rows. Columns 11 and 12 are left empty in all plates for the addition of controls (See Figure 2). 2

Compounds defined as individual mass and retention time combinations in UPLC/MS analysis with mass ion intensities 10 x over intensity threshold 3

Compounds which are unique to one extract (i.e. do not occur in any other extracts within the superset)

Extract 1 Extract 2 Extract 3 Extract 4

A B C D E F G H

1 F1 F11 F1 F11 F1 F11 F1 F11

2 F2 F12 F2 F12 F2 F12 F2 F12

3 F3 F13 F3 F13 F3 F13 F3 F13

4 F4 F14 F4 F14 F4 F14 F4 F14

5 F5 F15 F5 F15 F5 F15 F5 F15

Figure 2. Plate layout of samples

-4-

6 F6 F16 F6 F16 F6 F16 F6 F16

7 F7 F17 F7 F17 F7 F17 F7 F17

8 F8 F18 F8 F18 F8 F18 F8 F18

9 F9 F19 F9 F19 F9 F19 F9 F19

10 F10 F20 F10 F20 F10 F20 F10 F20

11

12

Merlion Pharmaceuticals Pte Ltd 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528 Tel. (65) 6829 5600 Fax. (65) 6829 5601 www.merlionpharma.com

Storage and Use The superset libraries contain lyophilized pre-fractionated and crude extract material in sealed ° polypropylene 96-well microtitre plates. They should be stored at or below 4 C until reconstituted. Reconstitution should be performed either in neat DMSO or in a DMSO/water solution as appropriate. °

(i)

Reconstitution in DMSO: Store below -20 C. Use within 1 year. Warning: freeze-thawing may result in precipitation of some material and should be avoided as much as possible.

(ii)

Reconstitution in DMSO/water or DMSO/buffer: Store at 4 C. Use within 2 weeks.

°

It is recommended that screening be repeated at more than one concentration to identify the most appropriate screening concentration and to help identify fractions with the most potent activity. Initially, it may be appropriate to screen samples at an ~FAC of 20 µg/mL. Example: Each well (containing ~20 µg material) is reconstituted in 50 µL DMSO/water (8:1) to give a stock solution of 0.4 mg/mL. This is diluted twenty-fold in the assay to give ~FAC of 20 µg/mL.

Hit analysis Following testing of the Supersets within an assay system the customer should notify MerLion of hit fractions which can then be the sub-fractionated and analysed in order to identify potential target compounds for isolation. The objective is to gain as much information as possible on the likely active compounds and to exclude known compounds (“dereplication”) before committing to large scale isolation, therefore saving considerable time and expense. These services are charged on a fee-forservice basis. Hit progression is typically as follows (also see Figure 3): 1.

Customer tests Superset fractions in assay – At appropriate concentration to identify specific hit fractions – Notifies MerLion of hit fractions

2.

Sub-fractionation of hits – Sub-fractions supplied for testing

3.

Customer tests sub-fractions in assay – Notifies MerLion of hit sub-fractions

4.

Dereplication for known compounds – LCMS matching of compounds in active sub-fractions versus MerLion database – High resolution (HR)-MSMS analysis of non-dereplicated sub-fractions – DNP query for matching masses – Identification of potential target compounds

5.

Estimate yield of target compounds – 30 min UPLC/ELSD/MS of crude extract to provide accurate quantification – Provide quote for compound isolation and structure elucidation

6.

Select target compounds for isolation

-5-

Merlion Pharmaceuticals Pte Ltd 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528 Tel. (65) 6829 5600 Fax. (65) 6829 5601 www.merlionpharma.com

Super producer selection Fermentation and extract generation

Fractionation (prep HPLC)

Array fractions into Supersets

 Test Supersets in assays Bulk fraction

 Sub-fractionation of hits (HPLC) Array sub-fractions

 Test sub-fractions in assays  Dereplication of hit sub-fractions

Identify target compounds

 Estimate target compound yield

 Select target compounds for isolation

Figure 3. Schematic of Superset generation and hit progression

-6-

Merlion Pharmaceuticals Pte Ltd 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528 Tel. (65) 6829 5600 Fax. (65) 6829 5601 www.merlionpharma.com

Safety This product contains cell free extracts and extract fractions from fungal strains isolated from diverse environments and localities. The samples contain uncharacterised chemicals and therefore should be handled as if potentially hazardous. Always wear personal protective equipment (laboratory gowns, safety spectacles and gloves) and dispose of as laboratory waste.

Other Products 1. Actinomycete superset (product code 18AS) 2. Pure natural product compound library (product code NP001)

-7-